权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

EUthyroid2 - The next step towards the elimination of iodine deficiency and preventable iodine-related disorders in Europe

EU甲状腺2 - 欧洲消除碘缺乏症和可预防的碘相关疾病的下一步

基本信息

批准号：
10062205
负责人：
金额：
$ 31.94万
依托单位：
UNIVERSITY OF SURREY
依托单位国家：
英国
项目类别：
EU-Funded
财政年份：
2023
资助国家：
英国
起止时间：
2023 至无数据
项目状态：
未结题

来源：
https://gtr.ukri.org/projects?ref=10062205
关键词：
EUthyroid2 next step towards elimination

项目摘要

The iodine status is a primary determinant of thyroid disorders, which are a major cause of morbidity, particularly in women. In addition, even mild-to-moderate iodine deficiency during pregnancy is related to neurocognitive impairment in the offspring. Iodine deficiency imposes tremendous costs on the health-care systems of affected regions, but can easily be prevented by iodine fortification programmes. In many countries, iodine deficiency receives surprisingly little publicity. The initial EUthyroid consortium evaluated European prevention programmes against iodine deficiency and uncovered major limitations including the low awareness on the importance of iodine for healthy living. EUthyroid2 will now fill important gaps in the prevention of iodine deficiency in Europe and beyond. The main objective of EUthyroid2 is to improve the low awareness with respect to iodine deficiency-related risks in adolescents and young women. The major aim is to find best practice models for accessing and informing them to increase their awareness and to improve their iodine status in order to lay the foundation for their own thyroid and general health and that of their offspring. Implementation studies and community-based randomised-controlled trials will be conducted with the objective of increasing iodinerelated awareness in adolescents and young women up to age of 24 before pregnancy. The interventions are multimodal and performed in the two settings educational system and ambulatory care in eight study regions. As public health project EUthyroid2 is not only science, but will also serve our societies. Therefore, dissemination of findings to various sectors of our countries and the EU will be of utmost importance. By finding best practice models to raise the awareness on the importance of iodine for a healthy life of their own and their offspring in young people, EUthyroid2 will lay the foundation for a cost-effective way to eradicate iodine deficiency-related disorders.

碘状况是甲状腺疾病的主要决定因素，甲状腺疾病是发病率的主要原因，特别是在妇女中。此外，即使怀孕期间轻度到中度的碘缺乏也与后代的神经认知障碍有关。缺碘给受影响地区的卫生保健系统带来了巨大的成本，但通过强化碘计划可以很容易地预防。在许多国家，人们对缺碘的宣传出人意料地少之又少。最初的正常甲状腺联盟对欧洲预防缺碘方案进行了评估，发现了主要的局限性，包括对碘对健康生活的重要性的认识不足。欧盟甲状腺2现在将填补欧洲及其他地区在预防缺碘方面的重要空白。欧盟甲状腺2的主要目标是改善青少年和年轻妇女对与缺碘有关的风险的认识不足。主要目的是找到最佳做法模式，让他们了解和告知他们提高认识和改善他们的碘状况，以便为他们自己的甲状腺和一般健康以及他们的后代的健康奠定基础。将进行实施研究和以社区为基础的随机对照试验，目的是提高怀孕前青少年和24岁以下年轻妇女对碘的认识。干预措施是多模式的，在八个研究区域的教育系统和门诊护理两个环境中进行。作为公共卫生项目，EUTIID2不仅是科学，而且还将服务于我们的社会。因此，将调查结果传播给我们各国和欧盟的各个部门将是至关重要的。通过寻找最佳做法模式，提高年轻人对碘对自身及其后代健康生活的重要性的认识，欧盟甲状腺2将为以具有成本效益的方式根除与缺碘有关的疾病奠定基础。